April 2024
1. MEYER B, Stirzaker C, Ramkomuth S, Harvey K, et al
   Detailed DNA methylation characterisation of phyllodes tumours identifies a signature of malignancy and distinguishes phyllodes from metaplastic breast carcinoma.
   J Pathol. 2024;262:480-494.
   

   >> Share

   
   January 2024
2. JAHANGIR CA, Page DB, Broeckx G, Gonzalez CA, et al
   Image-based multiplex immune profiling of cancer tissues: translational implications. A report of the International Immuno-oncology Biomarker Working Group on Breast Cancer.
   J Pathol. 2024 Jan 17. doi: 10.1002/path.6238.
   

   >> Share

   
   October 2023
3. CHEN H, Li X, Li F, Li Y, et al
   Prediction of coexisting invasive carcinoma on ductal carcinoma in situ (DCIS) lesions by mass spectrometry imaging.
   J Pathol. 2023;261:125-138.
   

   >> Share

   
   September 2023
4. SIJNESAEL T, Richard F, Ratze MA, Koorman T, et al
   Canonical Kaiso target genes define a functional signature that associates with breast cancer survival and the invasive lobular carcinoma histological type.
   J Pathol. 2023 Sep 22. doi: 10.1002/path.6205.
   

   >> Share

   
   August 2023
5. THAGAARD J, Broeckx G, Page DB, Jahangir CA, et al
   Pitfalls in machine learning-based assessment of tumor-infiltrating lymphocytes in breast cancer: a report of the international immuno-oncology biomarker working group.
   J Pathol. 2023 Aug 23. doi: 10.1002/path.6155.
   

   >> Share

   
   
6. PAGE DB, Broeckx G, Jahangir CA, Verbandt S, et al
   Spatial analyses of immune cell infiltration in cancer: current methods and future directions. A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer.
   J Pathol. 2023 Aug 23. doi: 10.1002/path.6165.
   

   >> Share

   
   
7. THAKUR S, Haider S, Natrajan R
   Implications of tumour heterogeneity on cancer evolution and therapy resistance: lessons from breast cancer.
   J Pathol. 2023 Aug 16. doi: 10.1002/path.6158.
   

   >> Share

   
   
8. TSOI H, Lok J, Man EP, Cheng CN, et al
   Overexpression of BQ323636.1 contributes to anastrozole resistance in AR+ve/ER+ve breast cancer.
   J Pathol. 2023 Aug 9. doi: 10.1002/path.6157.
   

   >> Share

   
   May 2023
9. VERGHESE G, Li M, Liu F, Lohan A, et al
   Multiscale deep learning framework captures systemic immune features in lymph nodes predictive of triple negative breast cancer outcome in large-scale studies.
   J Pathol. 2023 May 25. doi: 10.1002/path.6088.
   

   >> Share

   
   April 2023
10. TARULLO SE, He Y, Daughters C, Knutson TP, et al
    Receptor for hyaluronan-mediated motility (RHAMM) defines an invasive niche associated with tumor progression and predicts poor outcomes in breast cancer patients.
    J Pathol. 2023 Apr 26. doi: 10.1002/path.6082.
    

    >> Share

    
    January 2023
11. ALBUSAYLI R, Graham JD, Pathmanathan N, Shaban M, et al
    Artificial intelligence based digital scores of stromal tumour-infiltrating lymphocytes and tumour-associated stroma predict disease specific survival in triple-negative breast cancer.
    J Pathol. 2023 Jan 27. doi: 10.1002/path.6061.
    

    >> Share

    
    September 2022
12. BEKKHUS T, Avenel C, Hanna S, Franzen Boger M, et al
    Automated detection of vascular remodeling in tumor-draining lymph nodes by the deep-learning tool HEV-finder.
    J Pathol. 2022;258:4-11.
    

    >> Share

    
    August 2022
13. TER STEEGE EJ, Boer M, Timmer NC, Ammerlaan CM, et al
    R-spondin-3 is an oncogenic driver of poorly differentiated invasive breast cancer.
    J Pathol. 2022 Aug 9. doi: 10.1002/path.5999.
    

    >> Share

    
    June 2022
14. JIANG T, Wei F, Xie K
    Clinical significance of pancreatic ductal metaplasia.
    J Pathol. 2022;257:125-139.
    

    >> Share

    
    March 2022
15. GADALETA E, Thorn GJ, Ross-Adams H, Jones LJ, et al
    Field cancerization in breast cancer.
    J Pathol. 2022 Mar 31. doi: 10.1002/path.5902.
    

    >> Share

    
    
16. VALENZUELA-PALOMO A, Bueno-Martinez E, Sanoguera-Miralles L, Lorca V, et al
    Splicing predictions, minigene analyses, and ACMG-AMP clinical classification of 42 germline PALB2 splice-site variants.
    J Pathol. 2022;256:321-334.
    

    >> Share

    
    February 2022
17. HONG Y, Limback D, Elsarraj HS, Harper H, et al
    Mouse-INtraDuctal (MIND): an in vivo model for studying the underlying mechanisms of DCIS malignancy.
    J Pathol. 2022;256:186-201.
    

    >> Share

    
    December 2021
18. GANZ HM, Buchmann B, Engelbrecht LK, Jesinghaus M, et al
    Generation of ductal organoids from normal mammary luminal cells reveals invasive potential.
    J Pathol. 2021;255:451-463.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share